Clinical Trials at Alaska Oncology and Hematology
As of September 2026, 9 paid clinical trials are recruiting at Alaska Oncology and Hematology, located at 2925 DEBARR ROAD, SUITE 300, ANCHORAGE, AK 99508, phone (907) 279-3155 in Anchorage, Alaska. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Gastroesophageal Junction Adenocarcinoma and Anatomic Stage II Breast Cancer AJCC v8. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
View the full facility profile →
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
9 clinical trials at Alaska Oncology and Hematology
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Common conditions studied in Anchorage
- Malignant Solid Neoplasm (5 active studies)
- Gastroesophageal Junction Adenocarcinoma (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Breast Cancer (3 active studies)
- Non-small Cell Lung Cancer (3 active studies)
- Stage IV Lung Cancer AJCC v8 (3 active studies)
Leading research sponsors in Anchorage
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Anchorage?
There are approximately 99 recruiting clinical trials in Anchorage, Alaska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Anchorage pay participants?
Most recruiting trials in Anchorage compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Anchorage?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Anchorage?
The most common conditions under active study in Anchorage include Malignant Solid Neoplasm (5), Gastroesophageal Junction Adenocarcinoma (4), Anatomic Stage II Breast Cancer AJCC v8 (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Anchorage?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Anchorage on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Anchorage?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Anchorage?
Recruiting research sites in Anchorage include Providence Alaska Medical Center, Katmai Oncology Group, Alaska Women's Cancer Care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Anchorage right now?
The largest active categories in Anchorage are Cancer & tumors (68), Mental health & behavior (2), Diabetes & metabolic (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Alaska Oncology and Hematology?
Alaska Oncology and Hematology is located at 2925 DEBARR ROAD, SUITE 300, ANCHORAGE, AK 99508. Use the Google Maps link in the intro above to get directions.
How do I contact Alaska Oncology and Hematology?
You can reach Alaska Oncology and Hematology by phone at (907) 279-3155. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.